Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.86 HKD | -1.00% |
|
-0.86% | -53.65% |
06-24 | ImmuneOnco Biopharmaceuticals Gets IND Approval for NMOSDs Drug Trial in China | MT |
06-03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
671M | - | - | ||||
122B | ||||||
115B | ||||||
26.64B | - | |||||
19.91B | - | |||||
16.32B |